The Changes of Urine Growth Factors Level
NCT06282731
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
74
Enrollment
OTHER
Sponsor class
Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG:
Silodosin
Sponsor
En Chu Kong Hospital